MétaCan
Menu
Back to cohort
Record W4412938215 · doi:10.1016/s2352-3018(25)00131-6

Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi process

2025· article· en· W4412938215 on OpenAlexaff
Chloe Orkin, Amy Paterson, Alexa Elias, Melanie Smuk, Kyle Ring, Alain Volny‐Anne, Alexandra Calmy, Aniruddha Hazra, Anna María Geretti, Asa Radix, Boghuma K Titanji, Bruno Spire, Carlos del Rı́o, Caroline Foster, Carolyn Bolton‐Moore, Claudia P. Cortés, Cristina Mussini, Daniel R. Kuritzkes, Darrell H. S. Tan, Estebán Martínez, Ferdinand W N M Wit, Fiona V Cresswell, François Venter, Itzchak Levy, Jason Zucker, Jean‐Michel Molina, Jennifer Hoy, José Ramón Arribas, Josep M. Llibre, Judith S. Currier, Jussi Sutinen, Kelly A. Gebo, Laura Waters, Magnus Gisslén, Mark O’Reilly, Marta Boffito, Melanie Thompson, Miłosz Parczewski, Mina John, Monica Gandhi, Nagalingeswaran Kumarasamy, Nicholas I. Paton, Nicola Mackie, Pedro Cahn, Rick Elion, Sebastian Noé, Sharon Walmsley, Simon Collins, Susan Cole‐Haley, Vanessa Apea, William R. Short, Yvonne Gilleece, Sara Paparini

Bibliographic record

VenueThe Lancet HIV · 2025
Typearticle
Languageen
FieldMedicine
TopicHIV/AIDS drug development and treatment
Canadian institutionsUniversity of TorontoUniversity Health NetworkSt. Michael's Hospital
FundersCenter for AIDS Research, University of WashingtonNational Institutes of HealthIndian Council of Medical ResearchModernaCilagNovocureAmgenViiV HealthcareBiogenGilead SciencesSanofiBristol-Myers SquibbAstraZenecaPfizerQueen Mary University of LondonEmory University
KeywordsRilpivirineMedicineDiscontinuationTenofovirHuman immunodeficiency virus (HIV)Family medicineInternal medicineAntiretroviral therapyViral load

Abstract

fetched live from OpenAlex

BACKGROUND: Definitions of virological failure and treatment discontinuation for long-acting injectable (LAI) cabotegravir and rilpivirine antiretroviral therapy are inconsistent in clinical practice and observational studies, which complicates interpretation and implementation of findings. The CONSENSUS-LAI study aimed to establish consistent definitions of virological failure and treatment discontinuation to enhance evidence transferability and support optimal clinical outcomes. METHODS: The study had two phases. Phase 1 was an international online survey exploring existing definitions of virological and treatment discontinuation, conducted between April 25 and July 1, 2024. Eligible participants were health-care professionals working in infectious disease or sexual health services who had provided care to at least ten people living with HIV in the past 6 months, had prescribed LAI cabotegravir and rilpivirine in clinical trials or clinical practice, and were able to give informed consent. Participants were recruited via social media and mailing lists of medical specialist societies. Phase 2 was a Delphi process, in which a panel of experts, selected to ensure representation from all six WHO regions, scored leading definitions from phase 1 on a 9-point Likert scale. The proposed definitions were scored according to four validity criteria: clarity, usability in the expert's setting, appropriateness across clinical purposes, and applicability across relevant population groups. Revisions were suggested in iterative rounds until consensus was reached. Consensus was predefined as at least 75% of experts agreeing or strongly agreeing (scores 7-9) with the validity criteria. FINDINGS: 386 LAI cabotegravir and rilpivirine prescribers across 28 countries completed the survey, revealing 15 definitions for virological failure on LAI cabotegravir and rilpivirine and nine for treatment discontinuation. 52 experts participated in the Delphi process. Consensus agreement on both definitions was reached after two rounds for all validity criteria. For virological failure, the consensus definition was as follows: (a) viral load 200 copies or more per mL or more on two occasions 2-4 weeks apart, or (b) a single viral load of more than 1000 copies per mL, and/or (c) emergent resistance, in the context of timely injections and prior suppression of less than 200 copies per mL, OR (d) unable to suppress viral load to less than 200 copies per mL on continuous therapy. For treatment discontinuation the consensus definition was as follows: people on LAI cabotegravir and rilpivirine who have missed two consecutive injections and have not taken oral bridging in the interim, irrespective of reason for discontinuation. INTERPRETATION: The consensus definitions provide a foundation for aligning practice and evaluating patient outcomes. Further validation of the viral load threshold for virological failure and the optimal viral load retesting window is required. FUNDING: ViiV Healthcare.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.009
Threshold uncertainty score0.231

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.086
GPT teacher head0.353
Teacher spread0.267 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations8
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueThe Lancet HIVSame topicHIV/AIDS drug development and treatmentFrench-language works237,207